Safety of abatacept administered intravenously in treatment of rheumatoid arthritis: integrated analyses of up to 8 years of treatment from the abatacept clinical trial program (Q43829469)
Jump to navigation
Jump to search
scientific article published on 15 April 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety of abatacept administered intravenously in treatment of rheumatoid arthritis: integrated analyses of up to 8 years of treatment from the abatacept clinical trial program |
scientific article published on 15 April 2013 |
Statements
1 reference
Safety of abatacept administered intravenously in treatment of rheumatoid arthritis: integrated analyses of up to 8 years of treatment from the abatacept clinical trial program (English)
1 reference
Michael E Weinblatt
1 reference
Larry W Moreland
1 reference
Rene Westhovens
1 reference
Roger B Cohen
1 reference
Sheila M Kelly
1 reference
Nader Khan
1 reference
Ramesh Pappu
1 reference
Ingrid Delaet
1 reference
Allison Luo
1 reference
Sheila Gujrathi
1 reference
Marc C Hochberg
1 reference
15 April 2013
1 reference
1 reference
40
1 reference
6
1 reference
787-797
1 reference
Identifiers
1 reference
1 reference